{"filing":{"accession_number":"0001493152-26-036557","cik":"0000719135","ticker":"APYX","company_name":"Apyx Medical Corp","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-06","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226036557/form8-k.htm"},"events":[{"id":26201,"run_id":23798,"accession_number":"0001493152-26-036557","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Apyx Medical held its Annual Meeting of Stockholders on August 6, 2026, with voting results on four proposals: election of five directors, ratification of RSM US LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the 2026 Share Incentive Plan. Detailed vote tallies (votes in favor, against, abstained, and broker non-votes) were disclosed for each proposal.","company_name":"Apyx Medical Corp","ticker":"APYX","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":27234,"accession_number":"0001493152-26-036557","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Share Incentive Plan, a compensatory arrangement for officers and directors. While Item 5.02 covers multiple topics, the substantive content here is the adoption of a new equity incentive plan, which is a material compensation governance event affecting future executive compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:16:18.137939+00:00","company_name":"","ticker":null,"filing_date":""},{"id":27235,"accession_number":"0001493152-26-036557","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the final voting results from Apyx Medical's August 6, 2026 Annual Meeting of Stockholders on four proposals: election of five directors, ratification of RSM US LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the 2026 Share Incentive Plan. The filing presents detailed vote tallies (votes in favor, against, abstained, and broker non-votes) for each proposal, which is the core content of a shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:16:18.137939+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27234,"accession_number":"0001493152-26-036557","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Share Incentive Plan, a compensatory arrangement for officers and directors. While Item 5.02 covers multiple topics, the substantive content here is the adoption of a new equity incentive plan, which is a material compensation governance event affecting future executive compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:16:18.137939+00:00","company_name":"Apyx Medical Corp","ticker":"APYX","filing_date":"2026-08-07"},{"id":27235,"accession_number":"0001493152-26-036557","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the final voting results from Apyx Medical's August 6, 2026 Annual Meeting of Stockholders on four proposals: election of five directors, ratification of RSM US LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the 2026 Share Incentive Plan. The filing presents detailed vote tallies (votes in favor, against, abstained, and broker non-votes) for each proposal, which is the core content of a shareholder_vote_results event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:16:18.137939+00:00","company_name":"Apyx Medical Corp","ticker":"APYX","filing_date":"2026-08-07"}]}